Matrix Partners China
Venture capitalBeijing · Seed–Late Stage · 6 people tracked
Find your way into Matrix Partners China
235 people in our graph share verified history with the Matrix Partners China team — schools, employers, funds. One of them is your warm intro.
Investment thesis
The firm seeks outstanding entrepreneurs, whether starting out or building again, and has extensive experience backing first-time founders as well as companies still at the idea stage. It prioritizes the founder's mindset, track record and growth potential over polished presentation skills, favoring capital-efficient industry pioneers that can scale quickly. The firm prefers to engage founders early, ideally before a formal fundraise begins, and aims to be a company's first institutional investor and largest non-management shareholder. It remains flexible about seed-stage and later-stage opportunities and provides ongoing follow-on investment as portfolio companies' needs evolve.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from public directories
What they invest in
from 9 of 9 portfolio companiesAI & Machine Learning ×4Biotech ×4Deep Tech ×3AgTech ×2Data & Infrastructure ×2Enterprise Software ×2Fintech ×2FoodTech ×2
HQs:China×4United States×3United Kingdom×1
Investments · 9 tracked
founders shown can be your intro pathBy year:2022 · 12020 · 34 dated
Grandomics develops third-generation sequencing services and precision genomic medicine solutions for medical diagnostics, plant and animal breeding, and species conservation.
AgTechAI & Machine LearningBiotechData & InfrastructureDigital HealthMedical DevicesBeijing, CN
汪德鹏(CEO and Head of Technology Services BU)王洋(Executive Vice President and Chief Sequencing Technology Officer)赵云龙(Chief Operating Officer)
Co-investorsVitalbridge CapitalMarathon Venture Partners
Bota offers engineered protein solutions through strain optimization and screening, leveraging proprietary datasets to increase protein yield while reducing production costs for industrial biotech applications.
Advanced ManufacturingBiotechDeep TechFoodTechNew Materials
Dr. Cheryl Cui(CEO)
Co-investorsHongShan Capital GroupNSG VenturesSource Code CapitalSherpa Healthcare Partners
Dao Foods is an investment and advocacy firm that funds and mentors plant-based and alternative protein companies focused on or serving the Chinese market.
AgTechClimate TechFoodTechImpact & Social Good
Tao Zhang(Co-Founder)inAlbert Tseng(Co-Founder)in
Co-investorsUnovis Asset ManagementBluestein VenturesBuilders VCCongruent VenturesJoy CapitalNàdarra Ventures+4 more
Fabric is a venture capital firm backing Web3 and AI-focused companies from pre-seed to growth stage, with a thesis grounded in building human-centric applications for the machine economy.
AI & Machine LearningCrypto & Web3Deep TechFintechLondon, GB
Richard(Co-founder)Anil(Co-founder)Alain(Co-founder)Max
Co-investorsFirestartrPeakAccelerator VenturesCambridge AssociatesDN CapitalEIF+4 more
Nutshell provides customer relationship management and sales software designed for small businesses to increase revenue and improve team adoption of sales and marketing tools.
Enterprise SoftwareMarketing TechSaaSSales TechAnn Arbor, US
Andy Fowler(Co-founder)inGuy Suter(Co-founder)inIan Berry(Co-founder)in
Co-investorsID VenturesService Provider Capital
PingCAP develops TiDB, a cloud-native distributed SQL database built for scalability, strong consistency, and high availability.
Cloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareFintech
Co-investorsChina Growth CapitalCoatue ManagementMorningside Venture Capital LimitedAccess Technology VenturesGGV CapitalJeneration Capital+3 more
Rgenta develops orally available small molecule therapies that target RNA to address diseases previously considered undruggable, with programs in oncology (targeting proteins such as MYB in solid tumors and hematologic cancers) and central nervous system repeat expansion disorders like Huntington's disease.
AI & Machine LearningBiotechDeep TechHealthtechCambridge, US
Travis Wager(Co-founder, President and CSO)inHualin Simon Xi(Executive Officer, Director)Zhiping Weng(Co-founder)inSimon Xi(Co-founder and CEO)inJackie Walling(CMO)Debasish Roychowdhury(Director)
Co-investorsDelos CapitalVivo CapitalAMR Action FundBoehringer Ingelheim Venture FundKorea Investment PartnersLilly Asia Ventures+1 more
SemiDrive designs automotive-grade processors for intelligent vehicle cabins, integrating CPU, GPU, AI accelerators, and video processing capabilities.
AI & Machine LearningIoTSemiconductorsBeijing, CN
Co-investorsLenovo Capital and Incubator Group (LCIG)Vertex Ventures ChinaSequoia CapitalShanghai STVC GroupVertex VenturesWalden International
Tallac Therapeutics is a clinical-stage biopharmaceutical company developing oligonucleotide-based antibody conjugates (TRAAC candidates) designed to deliver immune-activating agents to tumor microenvironments for oncology indications.
BiotechHealthtechMedical DevicesBurlingame, US
Hong Wan(Executive Officer, Director)in
BoardRan Geng(Director)Michael Carusi(Director)Isaac Cheng(Director)Christine Brennan(Director)Corey Goodman(Director)in
Co-investorsLightstone VenturesMRL Ventures FundvenBio PartnersvenBio Global Strategic
Portfolio news
latest coverage across their companiesNutshell · archive.ph · Sep 9, 2026
SemiDrive · newmarketpitch.com · Mar 11, 2026
Fabric Ventures · trysignalbase.com · Feb 26, 2026
Frequently asked questions
- How many investments has Matrix Partners China made?
- Matrix Partners China has 9 tracked investments.
- What stage does Matrix Partners China invest at?
- Matrix Partners China invests at the Seed, Series A, Series B, Growth, Late Stage stages.
- What is Matrix Partners China's typical check size?
- Matrix Partners China typically writes checks of $1.6M – $113M.
- What sectors does Matrix Partners China focus on?
- Matrix Partners China focuses on AI & Machine Learning, Biotech, Consumer, Deep Tech, Enterprise Software, Hardware, Healthtech, Media & Entertainment, SaaS, Sector Agnostic.
- Where is Matrix Partners China located?
- Matrix Partners China is headquartered in Beijing, CN.
- Does Matrix Partners China lead rounds?
- Yes, Matrix Partners China leads investment rounds.
Similar investors
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
Industrial Technology Investment Corporation is the venture capital arm of Taiwan's Industrial Technology Research Institute (ITRI), backing startups across multiple stages and sectors while providing access to ITRI's R&D resources.
Venture Science is an investment firm applying research, mathematics, and decision theory to venture capital and public markets, powered by its proprietary in-house AI platform called Helix and its evergreen flagship fund Strata.
Olive Tree Capital invests in technology and life sciences companies, backing entrepreneurs across healthcare, fintech, enterprise, AI/ML, and frontier technology sectors.
Metaplanet is an evergreen investment firm that backs mission-driven founders building deep technologies aimed at supporting humanity's long-term survival and flourishing.